NLNK 26.84 - FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of Their Ebola Vaccine http://www.marketwatch.com/story/fda-gives-newlink-genetics-approval-to-proceed-to-phase-1-clinical-studies-of-their-ebola-vaccine-2014-09-04?siteid=bigcharts&dist=bigcharts